GGrantIndex
← Leaderboards

Jonathan Harvey Soslow

Vanderbilt University Medical Center

$5,426,669
Attributed
$8,790,303
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY201425
$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,328,024 · 5
FDA$2,462,279 · 1

By mechanism

R01$6,747,554 · 3
K23$829,360 · 1
R56$768,551 · 1
R61$444,838 · 1

Top collaborators

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Caring

Research focus

CaringCardiomyopathiesCardiovascular SystemCardiacBiological MarkersBloodImageCause Of DeathCoronary FibrosisInnovationMortalityMyocardialClinical TrialsScreeningChildhoodExtracellularInflammationMyocardiumQuality Of LifeLeft Ventricular Ejection FractionMorbidity - Disease RateDystrophinFutureInsight

Grant awards (18)

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials$738,341
R01 · FY2025 · HL · contact PI
Predictive modeling of acute rejection in pediatric heart transplant recipients$678,800
R01 · FY2025 · HL · contact PI
CHERISH (duCHennE caRdiomyopathy mItigation Sglt2 inHibitor)$444,838
R61 · FY2025 · HL
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials$838,348
R01 · FY2024 · HL · contact PI
Prospective Development of a Multimodal Biomaker Platform for Predictive Risk Stratification of Cardiac Disease in Duchenne Muscular Dystrophy$675,698
R01 · FY2024 · FD · contact PI
Predictive modeling of acute rejection in pediatric heart transplant recipients$658,355
R01 · FY2024 · HL · contact PI
Predictive modeling of acute rejection in pediatric heart transplant recipients$666,158
R01 · FY2023 · HL · contact PI
Prospective Development of a Multimodal Biomaker Platform for Predictive Risk Stratification of Cardiac Disease in Duchenne Muscular Dystrophy$604,256
R01 · FY2023 · FD · contact PI
Predictive modeling of acute rejection in pediatric heart transplant recipients$705,273
R01 · FY2022 · HL · contact PI
Prospective Development of a Multimodal Biomaker Platform for Predictive Risk Stratification of Cardiac Disease in Duchenne Muscular Dystrophy$577,922
R01 · FY2021 · FD · contact PI
Prospective Development of a Multimodal Biomaker Platform for Predictive Risk Stratification of Cardiac Disease in Duchenne Muscular Dystrophy$604,403
R01 · FY2019 · FD · contact PI
Development of a Multimodal Biomaker Platform for Predictive Risk Stratification of Cardiac Disease in Duchenne Muscular Dystrophy$768,551
R56 · FY2018 · HL · contact PI
Quantitative Assessment of Cardiac Disease in Duchenne Muscular Dystrophy$174,852
K23 · FY2018 · HL · contact PI
Quantitative Assessment of Cardiac Disease in Duchenne Muscular Dystrophy$174,852
K23 · FY2017 · HL · contact PI
Quantitative Assessment of Cardiac Disease in Duchenne Muscular Dystrophy$174,852
K23 · FY2016 · HL · contact PI
Quantitative Assessment of Cardiac Disease in Duchenne Muscular Dystrophy$79,590
K23 · FY2015 · HL · contact PI
Quantitative Assessment of Cardiac Disease in Duchenne Muscular Dystrophy$72,812
K23 · FY2015 · HL · contact PI
Quantitative Assessment of Cardiac Disease in Duchenne Muscular Dystrophy$152,402
K23 · FY2014 · HL · contact PI